A wild week for stocks has bonds playing defense again for first time in years
[ad_1] Bonds have returned to playing defense over the past week for the first time since the Federal Reserve started raising interest rates more than
CVS’s stock falls as the healthcare-benefits business continues to hurt profits
[ad_1] CVS’s CEO said the company is “taking action” to address its challenges, including making leadership changes in some business segments. [ad_2] Source link
Homeowners are flocking to HELOCs. Watch out for these pitfalls.
[ad_1] Homeowners across the U.S. are sitting on record levels of housing wealth, but cashing in without a clear need is a bad idea, one
Consumers feel frustrated with the housing market. Buying a house is unaffordable, Fannie Mae says.
[ad_1] Consumers are feeling frustrated by the housing market as home prices march to new heights, a new survey says. [ad_2] Source link
‘You’re not stupid enough to have to work in a place like this’: It’s time to give fast-food workers some respect. Could you do what they do?
[ad_1] A 39-year-old woman in Parma, Ohio was sentenced to two months working in a fast-food restaurant after throwing a hot bowl in a Chipotle
Nvidia’s stock offers ‘tremendous opportunity’ after selloff, this analyst says
[ad_1] Nvidia shares closed at $104.25 on Tuesday, well off their $135.58 closing high and $140.76 intraday high from June. [ad_2] Source link
Lyft swings to a profit on record rides, but its earnings outlook comes in light
[ad_1] Lyft turned its first GAAP profit in its latest quarter, while reporting a record number of rides and its largest quarterly haul of new
‘My son gets zero’: I’m leaving $1 million to my daughter. My son said he’ll convince my ex-wife to leave everything to him. Should I split my assets 50/50?
[ad_1] “I could write a book about how mean my son was to me.” [ad_2] Source link
Puma shares slump after sportswear group trims profit forecasts
[ad_1] Puma shares tumbled 13% on Wednesday after the German sportswear maker narrowed its profit forecast for the year, citing cautious consumer sentiment and higher
Ozempic maker Novo Nordisk misses profit estimates as it builds out capacity
[ad_1] Novo Nordisk, Europe’s largest company by market cap thanks to its wildly popular weight-loss drugs, managed just a small increase in second-quarter profits as